Medicine and Dentistry
Hazard Ratio
83%
Nucleotide
66%
Direct Oral Anticoagulant
66%
Apixaban
66%
Thromboembolism
66%
Rivaroxaban
50%
Haplotype
33%
Bleeding
33%
Dabigatran
33%
Assessment
33%
Association
33%
Proportional Hazards Model
16%
Genetic Variability
16%
Drug
16%
Cytochrome P450 3A5
16%
Breast Cancer Resistance Protein
16%
Chemotherapeutic Agent
16%
Gene
16%
Incidence
16%
Genotype
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenetics
100%
Nucleotide
66%
Thromboembolism
66%
Apixaban
66%
Rivaroxaban
50%
Dabigatran
33%
Bleeding
33%
Cytochrome P450 3A5
16%
ABCG2
16%
Drug
16%
Incidence
16%
Nursing and Health Professions
Thromboembolism
66%
Apixaban
66%
Nucleotide
66%
Rivaroxaban
50%
Dabigatran
33%
Breast Cancer Resistance Protein
16%
Cytochrome P450 3A5
16%
Psychology
Hazard Ratio
83%
Nucleotide
66%
Research
16%
Healthcare
16%
Proportional Hazards Regression Model
16%
Regression Model
16%
Biochemistry, Genetics and Molecular Biology
Rivaroxaban
50%
CYP3A5
16%